C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
06/2011
06/01/2011	CN102083800A Heteroaryl compounds and uses thereof
06/01/2011	CN102083798A Ruthenium olefin metathesis catalysts bearing N-heterocyclic carbene ligands with substituted backbone
06/01/2011	CN102083793A Protease inhibitors
06/01/2011	CN102079743A Dipeptidyl peptidase inhibitors
06/01/2011	CN102079728A Tripolycyanamide analogue, preparation method of tripolycyanamide analogue and intermediate used in preparation method
06/01/2011	CN102079727A Novel processes for the preparation of a 2h-chromene
06/01/2011	CN102079726A Miazine compounds, intermediates of miazine compounds, preparation method of intermediates and miazine compounds as well as application of miazine compound
06/01/2011	CN102079725A Method for preparing 2-chloropyrimidine
05/2011
05/31/2011	US7951942 Crystals of phenylalanine derivatives and production methods thereof
05/31/2011	US7951830 Compounds effecting glucokinase
05/31/2011	US7951820 Triazole compounds useful as protein kinase inhibitors
05/31/2011	US7951809 Inhibitors of p38
05/31/2011	US7951808 Imidazole compounds
05/31/2011	US7951804 Inhibitors of coagulation factors; Thrombosis, tumors, myocardial infarction, arteriosclerosis, inflammation, apoplexy, angina pectoris, restenosis; example, 1-(4-chlorophenyl)-3-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-phenylethyl]urea
05/31/2011	US7951803 8-heteroarylpurine MNK2 inhibitors for treating metabolic disorders
05/31/2011	US7951592 Compositions and methods for inducing cell dedifferentiation
05/31/2011	CA2634299C Process for preparing inhibitors of nucleoside metabolism
05/31/2011	CA2475764C New inhibitors of histone deacetylase
05/26/2011	WO2011063072A2 Process for the preparation of substituted phenylalanines
05/26/2011	WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same
05/26/2011	WO2011062253A1 Novel fused pyrimidine derivative
05/26/2011	WO2011061243A1 Heterocyclic antiviral compounds
05/26/2011	WO2011060873A1 Quinazoline derivatives
05/26/2011	WO2011060624A1 Process for preparing 2-methyl-4-amino-5-cyanopyrimidine
05/26/2011	WO2010051926A3 Halogen-substituted compounds used as pesticides
05/26/2011	US20110124865 Process for the preparation of substituted phenylalanines
05/26/2011	US20110124864 Preparation method of rosuvastatin calcium and its intermediates
05/26/2011	US20110124669 Modulators of Cellular Adhesion
05/26/2011	US20110124666 3,4-dihydropyrimidine trpa1 antagonists
05/26/2011	US20110124664 Polycationic Compounds And Uses Thereof
05/26/2011	US20110124651 Fluorine-containing organosulfur compound and pesticidal composition thereof
05/26/2011	US20110124650 Stable crystalline salts of antifolate compounds
05/26/2011	US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
05/26/2011	US20110123489 Heterocyclic antiviral compounds
05/26/2011	DE102009054302A1 Chinazolinderivate Quinazoline derivatives
05/26/2011	CA2781380A1 Quinazoline derivatives
05/26/2011	CA2780203A1 Process for the preparation of substituted phenylalanines
05/26/2011	CA2778206A1 Heterocyclic antiviral compounds
05/25/2011	EP2325175A1 2,4-diaminopyrimidine compound
05/25/2011	EP2325170A1 Substituted quinolinones having herbicidal action
05/25/2011	EP2323993A2 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
05/25/2011	EP2323992A1 5-alkynyl-pyrimidines
05/25/2011	EP2323987A1 N-myristoyl transferase inhibitors
05/25/2011	EP2212297B1 Inhibitors of protein kinases
05/25/2011	EP1781294B1 Composition for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
05/25/2011	CN1930166B 5,6-dialkyl-7-amino-triazolopyrimidines, method for their production, their use for controlling pathogenic fungi and compositions containing said compounds
05/25/2011	CN1680325B Preparation of pyridine derivatives
05/25/2011	CN1578663B Inhibitors of histone deacetylase
05/25/2011	CN102076668A Substituted quinazolines
05/25/2011	CN102070538A Method for preparing azoxystrobin
05/25/2011	CN102070537A Rosuvastatin calcium compound and novel refining method thereof
05/25/2011	CN102070536A Method for preparing 2,4-dichloro-5-fluoropyrimidine compound
05/25/2011	CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
05/25/2011	CN101284247B Dinuclear nickel cross-coupling reaction catalyst supported by nitrogen heterocycle carbine ligand and preparation method thereof
05/25/2011	CN101175730B Method for preparing substituted pyrimidines
05/25/2011	CN101068793B Potassium salt of an HIV integrase inhibitor
05/25/2011	CN101014576B Aryl spirolactam cgrp receptor antagonists
05/24/2011	US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands
05/24/2011	US7947698 Prevent trabsplant rejection; autoimmune diseases
05/24/2011	US7947690 Insulin secretagogue and hypoglycemic agent; pyrimidine derivatives condensed with a non-aromatic ring selected from dihydrothiophene, dihydrofuran, cycloalkane moiety; 1-[2-(4-chloro-2,5-difluorophenyl)-6,6-dioxido-5,7-dihydrothieno[3,4-d]pyrimidin-4-yl]-4-(3-hydroxypropyl)piperidin-4-ol for example
05/24/2011	CA2490888C Diaminopyrimidinecarboxamide derivative
05/24/2011	CA2464807C Phenyl-propargylether derivatives
05/24/2011	CA2440280C Substituted fluoroalkoxyphenylsulfonylurea
05/24/2011	CA2393710C Caspase inhibitors and uses thereof
05/19/2011	WO2011058525A2 Processes for the preparation of erlotinib hydrochloride form a and erlotinib hydrochloride form b
05/19/2011	WO2011024056A3 An improved process for the preparation of bosentan
05/19/2011	WO2011017342A3 Mesoionic pesticides
05/19/2011	WO2010151644A3 Antineoplastic hydrogels, and enzyme-instructed preparations thereof
05/19/2011	WO2010149598A3 Heterocyclic antiviral compound
05/19/2011	US20110118470 Nitrogen-containing aromatic derivatives
05/19/2011	US20110118465 Process for stereoselective synthesis of lamivudine
05/19/2011	US20110118258 Quinazolin-oxime derivatives as hsp90 inhibitors
05/19/2011	US20110118245 Raf kinase modulator compounds and methods of use thereof
05/19/2011	US20110118244 Factor xa inhibitors
05/19/2011	US20110118232 Pyrimidine compounds and use thereof
05/19/2011	US20110118199 Use of cns penetrating anticancer compounds for the treatment of protozoal diseases
05/19/2011	US20110117659 Quinazoline-containing kits for labeling aldehyde or ketone moieties
05/19/2011	US20110117073 Protein Kinase Conjugates and Inhibitors
05/19/2011	CA2781056A1 Kinase inhibitors
05/18/2011	EP2322628A2 Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322627A2 Mutations in the BCR-abl tyrosine kinase associated with resistance to STI-571
05/18/2011	EP2322534A1 Antiviral nucleosides
05/18/2011	EP2322513A2 Intermediates
05/18/2011	EP2321284A1 Sulfone substituted quinazoline derivatives as immune-modulators for the treatment of inflammatory and allergic diseases
05/18/2011	EP2321283A1 2, 6-diamino-pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors
05/18/2011	EP1943232B1 Squaric acid derivatives as inhibitors of histone deacetylase
05/18/2011	EP1781622B1 Integrin alpha-v beta-3 antagonists for use in imaging and therapy
05/18/2011	EP1373210B1 Heterocyclic diamide invertebrate pest control agents
05/18/2011	CN102066341A Substituted quinazolines
05/18/2011	CN102066340A 2, 6-diamino-pyrimidin- 5-yl-carboxamides as SRK or JAK kinases inhibitors
05/18/2011	CN102066339A 2, 6-diamino- pyrimidin- 5-yl-carboxamides as SYK or JAK kinases inhibitors
05/18/2011	CN102066338A Inhibitors of protein kinases
05/18/2011	CN102066337A 5-hydroxypyrimidine-4-carboxamide compound
05/18/2011	CN102066336A 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides
05/18/2011	CN102066335A Substituted pyrimidin-5-carboxamides 281
05/18/2011	CN102065693A Herbicidal compounds based on N-azinyl-N'-phenylsulfonylureas
05/18/2011	CN102060806A Cytokine inhibitors
05/18/2011	CN102060786A 4-(substituted-1,3-diyne)-4-(trifluoromethyl)-3,4-dihydro substituted quinazoline-2-ketone compound as well as preparation method and application thereof
05/18/2011	CN102060785A Synthesis process of methiopyrsulfuron
05/18/2011	CN102060784A Method for synthesizing 6-ethyl-5-fluoro-4-hydroxy pyrimidine and intermediate thereof

1 ... 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 ... 427